Analysis of Gut Microbiota Signature and Microbe-Disease Progression Associations in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy

Analysis of Gut Microbiota Signature and Microbe-Disease Progression Associations in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy

PurposeTo evaluate the association of gut microbiome signature and disease progression in locally advanced non-small cell lung cancer (LA-NSCLC) patients treated with concurrent chemoradiotherapy (CCRT) by fecal metagenome analysis.MethodsMetagenome-wide association studies on baseline fecal samples...

Full description

Bibliographic Details
Main Authors: Yu Xi, FangJie Liu, Bo Qiu, Ying Li, XinQiang Xie, JinYu Guo, Lei Wu, TingTing Liang, DaQuan Wang, Juan Wang, Moutong Chen, Liang Xue, Yu Ding, Jumei Zhang, QingPing Wu, Hui Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
non-small cell lung cancer
gut microbiota
chemoradiotherapy
disease progression
metagenomes
antibiotic resistance genes
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.892401/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2022.892401/full

Similar Items